1. Home
  2. CASS vs EOLS Comparison

CASS vs EOLS Comparison

Compare CASS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASS
  • EOLS
  • Stock Information
  • Founded
  • CASS 1906
  • EOLS 2012
  • Country
  • CASS United States
  • EOLS United States
  • Employees
  • CASS N/A
  • EOLS N/A
  • Industry
  • CASS Business Services
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CASS Consumer Discretionary
  • EOLS Health Care
  • Exchange
  • CASS Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • CASS 588.1M
  • EOLS 702.2M
  • IPO Year
  • CASS 1996
  • EOLS 2018
  • Fundamental
  • Price
  • CASS $43.18
  • EOLS $13.99
  • Analyst Decision
  • CASS Buy
  • EOLS Strong Buy
  • Analyst Count
  • CASS 1
  • EOLS 6
  • Target Price
  • CASS $45.00
  • EOLS $23.80
  • AVG Volume (30 Days)
  • CASS 45.7K
  • EOLS 824.4K
  • Earning Date
  • CASS 04-17-2025
  • EOLS 03-04-2025
  • Dividend Yield
  • CASS 2.87%
  • EOLS N/A
  • EPS Growth
  • CASS N/A
  • EOLS N/A
  • EPS
  • CASS 1.39
  • EOLS N/A
  • Revenue
  • CASS $219,894,000.00
  • EOLS $248,326,000.00
  • Revenue This Year
  • CASS N/A
  • EOLS $34.38
  • Revenue Next Year
  • CASS $7.70
  • EOLS $31.94
  • P/E Ratio
  • CASS $31.06
  • EOLS N/A
  • Revenue Growth
  • CASS 3.13
  • EOLS 34.42
  • 52 Week Low
  • CASS $37.99
  • EOLS $9.25
  • 52 Week High
  • CASS $49.16
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • CASS 51.44
  • EOLS 54.04
  • Support Level
  • CASS $42.30
  • EOLS $14.50
  • Resistance Level
  • CASS $45.45
  • EOLS $15.06
  • Average True Range (ATR)
  • CASS 1.10
  • EOLS 0.86
  • MACD
  • CASS 0.08
  • EOLS -0.00
  • Stochastic Oscillator
  • CASS 55.84
  • EOLS 27.38

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: